ARYLAMIDDERIVATE ALS TTX-S-BLOCKER

European patent · EP2630122 · Deleted

Register entry

Publication number
EP2630122
Application number
EP11834032
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Oct 18, 2011
Published
Aug 28, 2013
Granted
Nov 30, 2016
Deleted
Oct 31, 2017
Reason
Annual fee unpaid
IPC classes
C07D 213/81 (2006.01)
A61K 31/44 (2006.01)
A61K 31/4427 (2006.01)
A61K 31/444 (2006.01)
A61K 31/506 (2006.01)
A61P 25/00 (2006.01)
A61P 29/00 (2006.01)
A61P 43/00 (2006.01)
C07D 213/64 (2006.01)
C07D 239/42 (2006.01)
C07D 401/04 (2006.01)
C07D 401/12 (2006.01)
C07D 401/14 (2006.01)
C07D 405/12 (2006.01)
C07D 413/12 (2006.01)
C07D 413/14 (2006.01)
C07D 417/14 (2006.01)
C07D 471/04 (2006.01)
Priority
US 201161522792 P 12.08.2011
US 418002 P 30.11.2010
US 394017 P 18.10.2010
PCT application
PCT/JP2011/005802 18.10.2011
PCT publication
WO2012/053186 26.04.2012
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 23, 2018

    Deleted, fee unpaid

    Published in Swissreg on 23.05.2018

  2. Nov 30, 2016

    Granted

    Published in Swissreg on 30.11.2016

Parties

Holder

RaQualia Pharma Inc.

RaQualia Pharma Inc

1-21-19 Meieki Minami, Nakamura-ku,, Nagoya-shi, Aichi 450-0003, JP

Inventor

YAMAGISHI, Tatsuya

Nagoya-shi Aichi 450-0003, JP

KAWAMURA, Kiyoshi

Nagoya-shi Aichi 450-0003, JP

ARANO, Yoshimasa

Nagoya-shi Aichi 450-0003, JP

MORITA, Mikio

Nagoya-shi Aichi 450-0003, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.